Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
和黃醫藥
HCM
5
Lantheus
LNTH
(FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | -22.78%42.71億 | -12.34%11.36億 | -21.78%10.63億 | -25.87%10.32億 | -29.90%10.4億 | -22.20%55.3億 | -22.91%12.96億 | -24.42%13.59億 | -24.06%13.92億 | -17.41%14.83億 |
營業收入 | -22.78%42.71億 | -12.34%11.36億 | -21.78%10.63億 | -25.87%10.32億 | -29.90%10.4億 | -22.20%55.3億 | -22.91%12.96億 | -24.42%13.59億 | -24.06%13.92億 | -17.41%14.83億 |
主營業務成本 | -18.56%39.47億 | -8.85%10.66億 | -14.10%10.02億 | -21.23%9.48億 | -28.77%9.31億 | -20.79%48.46億 | -21.76%11.7億 | -24.58%11.67億 | -21.05%12.03億 | -15.81%13.07億 |
毛利 | -52.66%3.24億 | -44.72%6,979.1萬 | -68.39%6,081.9萬 | -55.42%8,421.8萬 | -38.23%1.09億 | -30.91%6.84億 | -32.14%1.26億 | -23.41%1.92億 | -38.88%1.89億 | -27.61%1.76億 |
營業費用 | 6.47%8.88億 | 8.85%2.53億 | -22.97%1.55億 | 3.75%2.04億 | 35.44%2.76億 | -29.85%8.34億 | -3.86%2.33億 | -23.30%2.01億 | -42.16%1.96億 | -40.94%2.04億 |
銷售和管理費用 | -12.54%5.16億 | -7.93%1.51億 | -14.38%1.21億 | -6.36%1.25億 | -21.34%1.18億 | -36.49%5.89億 | -8.41%1.64億 | -34.25%1.41億 | -48.09%1.34億 | -45.57%1.5億 |
-銷售費用 | -11.54%3.11億 | -5.54%7,934.8萬 | -11.93%7,926萬 | -11.58%7,696.3萬 | -16.67%7,557萬 | -45.03%3.52億 | -32.21%8,399.76萬 | -44.49%8,999.6萬 | -48.02%8,704.7萬 | -51.34%9,068.6萬 |
-管理費用 | -14.02%2.04億 | -10.44%7,167.4萬 | -18.69%4,146.2萬 | 3.32%4,849.6萬 | -28.42%4,279.7萬 | -17.52%2.38億 | 45.05%8,003.08萬 | -2.51%5,099.4萬 | -48.23%4,693.8萬 | -33.64%5,979.3萬 |
研發費用 | -34.40%1.82億 | -42.19%3,415萬 | -41.96%4,324.3萬 | -29.43%5,013.5萬 | -25.12%5,415萬 | -27.71%2.77億 | -26.68%5,907.25萬 | -11.69%7,451萬 | -30.25%7,104.3萬 | -37.83%7,231.1萬 |
其他營業費用 | 690.47%1.91億 | 608.56%6,815.3萬 | 37.19%-896.4萬 | 427.21%2,818.9萬 | 643.04%1.03億 | 73.56%-3,231.45萬 | 154.71%961.85萬 | 60.85%-1,427.2萬 | 57.72%-861.5萬 | 60.16%-1,904.6萬 |
營業利潤 | -275.97%-5.64億 | -72.38%-1.84億 | -969.04%-9,418.2萬 | -1,491.23%-1.2億 | -511.99%-1.67億 | 24.54%-1.5億 | -90.07%-1.06億 | 20.74%-881萬 | 75.41%-751.4萬 | 73.04%-2,727.8萬 |
淨非營業利息收入(費用) | -7.70%2.63億 | -45.31%4,514.7萬 | -24.65%6,084萬 | 12.97%7,597.2萬 | 49.00%8,109.4萬 | 119.46%2.85億 | 49.41%8,255.61萬 | 134.72%8,074.7萬 | 185.33%6,725.2萬 | 227.24%5,442.6萬 |
利息收入 | -7.70%2.63億 | -45.31%4,514.7萬 | -24.65%6,084萬 | 12.97%7,597.2萬 | 49.00%8,109.4萬 | 119.46%2.85億 | 49.41%8,255.61萬 | 134.72%8,074.7萬 | 185.33%6,725.2萬 | 227.24%5,442.6萬 |
其他淨收入(費用) | 134.67%2,313.3萬 | 41.96%-2,085.5萬 | 3,043.91%4,417.2萬 | 98.51%-33.9萬 | 101.63%15.3萬 | 16.92%-6,671.46萬 | -103.10%-3,593.36萬 | 104.31%140.5萬 | 21.10%-2,279萬 | -717.75%-939.6萬 |
出售證券收益 | 880.99%123.5萬 | 547.15%54.6萬 | -1,850.00%-7萬 | -63.19%60.4萬 | 110.96%15.3萬 | --12.59萬 | ---12.21萬 | --4,000 | --164.1萬 | ---139.6萬 |
特殊收入(費用) | --0 | --0 | ---- | ---- | --0 | ---1,396.68萬 | ---- | ---- | ---- | --0 |
-減:資本性資產減值 | --0 | --0 | ---- | ---- | --0 | --1,396.68萬 | ---- | ---- | ---- | --0 |
其他非經營收入(費用) | 141.42%2,189.8萬 | 2.03%-2,140.1萬 | 3,057.89%4,424.2萬 | 96.14%-94.3萬 | ---- | 34.16%-5,287.37萬 | -23.47%-2,184.47萬 | 104.30%140.1萬 | 15.42%-2,443.1萬 | -596.26%-800萬 |
稅前利潤 | -507.69%-2.78億 | -166.08%-1.59億 | -85.23%1,083萬 | -218.90%-4,393.2萬 | -582.69%-8,569.2萬 | 145.67%6,819.73萬 | -224.34%-5,984.67萬 | 889.47%7,334.2萬 | 203.01%3,694.8萬 | 120.71%1,775.3萬 |
所得稅 | 1,341.31%1,540.7萬 | 504.70%646.4萬 | 643.2萬 | 251萬 | 0 | -69.34%106.9萬 | -69.34%106.9萬 | 0 | 0 | 0 |
除稅後的權益收益 | 87.34%-400.1萬 | 251.25%198.1萬 | -132.75%-99.4萬 | 90.94%-272.7萬 | 30.13%-226.1萬 | -150.66%-3,161.08萬 | -102.05%-130.98萬 | 14.66%303.5萬 | -942.60%-3,010萬 | -182.37%-323.6萬 |
除稅後利潤 | -937.45%-2.97億 | -163.12%-1.64億 | -95.54%340.4萬 | -818.01%-4,916.9萬 | -705.86%-8,795.3萬 | 139.28%3,551.76萬 | -248.71%-6,222.54萬 | 1,249.74%7,637.7萬 | 117.67%684.8萬 | 116.71%1,451.7萬 |
持續經營利潤 | -937.45%-2.97億 | -163.12%-1.64億 | -95.54%340.4萬 | -818.01%-4,916.9萬 | -705.86%-8,795.3萬 | 139.28%3,551.76萬 | -248.71%-6,222.54萬 | 1,249.74%7,637.7萬 | 117.67%684.8萬 | 116.71%1,451.7萬 |
歸屬於少數股東的淨利潤 | 0 | |||||||||
歸屬於母公司的淨利潤 | -937.45%-2.97億 | -163.12%-1.64億 | -95.54%340.4萬 | -818.01%-4,916.9萬 | -705.86%-8,795.3萬 | 147.09%3,551.76萬 | -237.30%-6,222.54萬 | 2,670.75%7,637.7萬 | 122.15%684.8萬 | 116.71%1,451.7萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | -937.45%-2.97億 | -163.12%-1.64億 | -95.54%340.4萬 | -818.01%-4,916.9萬 | -705.86%-8,795.3萬 | 147.09%3,551.76萬 | -237.30%-6,222.54萬 | 2,670.75%7,637.7萬 | 122.15%684.8萬 | 116.71%1,451.7萬 |
基本每股收益 | -969.37%-9.65 | -178.46%-5.43 | -95.40%0.11 | -852.38%-1.58 | -715.56%-2.77 | 147.03%1.11 | -237.32%-1.95 | 2,755.56%2.39 | 121.65%0.21 | 116.61%0.45 |
稀釋每股收益 | -969.37%-9.65 | -178.46%-5.43 | -95.40%0.11 | -852.38%-1.58 | -715.56%-2.77 | 147.03%1.11 | -237.32%-1.95 | 2,755.56%2.39 | 121.65%0.21 | 116.61%0.45 |
每股派息 | ||||||||||
貨幣單位 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | -- | -- | -- | -- | 無保留意見 | -- | -- | -- | -- |